Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $50,288 | 20 | 54.9% |
| Honoraria | $15,633 | 11 | 17.1% |
| Consulting Fee | $14,500 | 9 | 15.8% |
| Travel and Lodging | $7,803 | 36 | 8.5% |
| Food and Beverage | $3,241 | 42 | 3.5% |
| Education | $147.69 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ARGENX US, INC. | $38,987 | 45 | $0 (2024) |
| Amylyx Pharmaceuticals, Inc. | $19,799 | 38 | $0 (2024) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $15,848 | 15 | $0 (2024) |
| UCB, Inc. | $10,769 | 13 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $5,708 | 1 | $0 (2020) |
| ITF Pharma, Inc. | $194.60 | 1 | $0 (2022) |
| EDW Pharma, Inc. | $105.21 | 1 | $0 (2023) |
| Biogen, Inc. | $75.79 | 2 | $0 (2024) |
| EMD Serono, Inc. | $71.90 | 1 | $0 (2019) |
| Johnson & Johnson Vision Care, Inc. | $17.99 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39,999 | 41 | ARGENX US, INC. ($20,574) |
| 2023 | $32,007 | 54 | Amylyx Pharmaceuticals, Inc. ($17,383) |
| 2022 | $13,766 | 19 | ARGENX US, INC. ($13,554) |
| 2021 | $11.34 | 1 | Biogen, Inc. ($11.34) |
| 2020 | $5,708 | 1 | Biohaven Pharmaceuticals, Inc. ($5,708) |
| 2019 | $97.17 | 3 | EMD Serono, Inc. ($71.90) |
| 2018 | $23.88 | 2 | Mitsubishi Tanabe Pharma America, Inc. ($12.21) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Neurology | ||||||
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $158.12 | General |
| Category: Neurology | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Neurology | ||||||
| 11/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $129.08 | General |
| Category: Neurology | ||||||
| 11/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Neurology | ||||||
| 11/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $60.00 | General |
| Category: Neurology | ||||||
| 11/12/2024 | UCB, Inc. | Rystiggo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,680.00 | General |
| Category: Neurology | ||||||
| 11/01/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 10/29/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $111.23 | General |
| Category: Neurology | ||||||
| 10/22/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| Category: Neurology | ||||||
| 10/22/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $162.28 | General |
| Category: Neurology | ||||||
| 10/22/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Neurology | ||||||
| 09/25/2024 | ARGENX US, INC. | VYVGART (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,500.00 | General |
| Category: Immunology | ||||||
| 09/25/2024 | ARGENX US, INC. | VYVGART (Drug) | Travel and Lodging | Cash or cash equivalent | $44.00 | General |
| Category: Immunology | ||||||
| 09/25/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Immunology | ||||||
| 09/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $167.57 | General |
| Category: Neurology | ||||||
| 09/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $124.26 | General |
| Category: Neurology | ||||||
| 09/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $60.00 | General |
| Category: Neurology | ||||||
| 09/12/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA ORS (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 08/20/2024 | UCB, Inc. | Zilbrysq (Drug) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: Neurology | ||||||
| 08/16/2024 | Biogen, Inc. | — | Education | In-kind items and services | $64.45 | General |
| 08/03/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Immunology | ||||||
| 08/03/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $58.76 | General |
| Category: Immunology | ||||||
| 08/03/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Immunology | ||||||
| 08/03/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 374 | 465 | $112,336 | $44,689 |
| 2022 | 13 | 436 | 541 | $132,110 | $56,973 |
| 2021 | 15 | 427 | 526 | $123,097 | $55,061 |
| 2020 | 16 | 410 | 497 | $120,116 | $49,175 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 57 | 108 | $27,216 | $12,607 | 46.3% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 44 | 44 | $18,876 | $6,111 | 32.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 60 | 64 | $10,752 | $4,542 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 43 | $8,041 | $3,840 | 47.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 33 | 33 | $11,682 | $3,684 | 31.5% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 50 | 81 | $8,586 | $3,641 | 42.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 26 | $9,334 | $3,550 | 38.0% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 25 | 25 | $6,725 | $2,363 | 35.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $5,082 | $1,957 | 38.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,656 | $1,709 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,386 | $686.99 | 49.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 68 | 118 | $29,682 | $14,722 | 49.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 42 | 43 | $18,447 | $7,079 | 38.4% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 66 | 100 | $10,600 | $4,851 | 45.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 57 | 59 | $9,912 | $4,512 | 45.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 28 | $10,052 | $4,286 | 42.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 32 | 32 | $11,328 | $4,195 | 37.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 14 | 20 | $8,060 | $3,437 | 42.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $7,623 | $3,132 | 41.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 33 | $6,171 | $2,738 | 44.4% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 28 | 28 | $7,532 | $2,735 | 36.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 28 | $5,992 | $2,259 | 37.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $4,947 | $2,105 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 14 | $1,764 | $921.61 | 52.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 61 | 107 | $26,802 | $13,777 | 51.4% |
About Dr. John Novak, M.D
Dr. John Novak, M.D is a Neurology healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1619195880.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Novak, M.D has received a total of $91,613 in payments from pharmaceutical and medical device companies, with $39,999 received in 2024. These payments were reported across 121 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($50,288).
As a Medicare-enrolled provider, Novak has provided services to 1,647 Medicare beneficiaries, totaling 2,029 services with total Medicare billing of $205,898. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology
- Location Westerville, OH
- Active Since 04/23/2007
- Last Updated 08/02/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1619195880
Products in Payments
- VYVGART (Drug) $22,203
- RELYVRIO (Drug) $19,799
- RADICAVA (Drug) $12,836
- VYVGART HYTRULO (Drug) $10,611
- Zilbrysq (Drug) $8,935
- Rystiggo (Drug) $1,680
- RADICAVA ORS (Drug) $1,500
- Tiglutik (Drug) $194.60
- TIGLUTIK (Drug) $105.21
- Acuvue (Device) $17.99
- Reveal LINQ (Device) $14.30
- Radicava (Drug) $12.21
- AIMOVIG (Biological) $11.67
- SPINRAZA (Biological) $11.34
- Trilogy 100 (Device) $10.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Westerville
Dr. Alfred Paige, Md, MD
Neurology — Payments: $8,801
Dr. Jay Bauerle, Md, MD
Neurology — Payments: $3,169
Dr. Gregory Figg, Md, MD
Neurology — Payments: $1,330
Mrs. Deanna Parkhurst, Pt, PT
Neurology
Marina Giovannini
Neurology
Anna Tyler
Neurology